224 related articles for article (PubMed ID: 19439221)
1. An in vitro screening cascade to identify neuroprotective antioxidants in ALS.
Barber SC; Higginbottom A; Mead RJ; Barber S; Shaw PJ
Free Radic Biol Med; 2009 Apr; 46(8):1127-38. PubMed ID: 19439221
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Song L; Chen L; Zhang X; Li J; Le W
Biomed Res Int; 2014; 2014():483501. PubMed ID: 25057490
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target.
Barber SC; Shaw PJ
Free Radic Biol Med; 2010 Mar; 48(5):629-41. PubMed ID: 19969067
[TBL] [Abstract][Full Text] [Related]
4. γ-Oryzanol mitigates oxidative stress and prevents mutant SOD1-Related neurotoxicity in Drosophila and cell models of amyotrophic lateral sclerosis.
Zhang C; Liang W; Wang H; Yang Y; Wang T; Wang S; Wang X; Wang Y; Feng H
Neuropharmacology; 2019 Dec; 160():107777. PubMed ID: 31521619
[TBL] [Abstract][Full Text] [Related]
5. Rodent Models of Amyotrophic Lateral Sclerosis.
Philips T; Rothstein JD
Curr Protoc Pharmacol; 2015 Jun; 69():5.67.1-5.67.21. PubMed ID: 26344214
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection by urate on the mutant hSOD1-related cellular and Drosophila models of amyotrophic lateral sclerosis: Implication for GSH synthesis via activating Akt/GSK3β/Nrf2/GCLC pathways.
Zhang C; Yang Y; Liang W; Wang T; Wang S; Wang X; Wang Y; Jiang H; Feng H
Brain Res Bull; 2019 Mar; 146():287-301. PubMed ID: 30690059
[TBL] [Abstract][Full Text] [Related]
7. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis.
Bordet T; Buisson B; Michaud M; Drouot C; Galéa P; Delaage P; Akentieva NP; Evers AS; Covey DF; Ostuni MA; Lacapère JJ; Massaad C; Schumacher M; Steidl EM; Maux D; Delaage M; Henderson CE; Pruss RM
J Pharmacol Exp Ther; 2007 Aug; 322(2):709-20. PubMed ID: 17496168
[TBL] [Abstract][Full Text] [Related]
9. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
[TBL] [Abstract][Full Text] [Related]
10. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.
Chi L; Ke Y; Luo C; Gozal D; Liu R
Neuroscience; 2007 Feb; 144(3):991-1003. PubMed ID: 17150307
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of growth hormone on Cu/Zn superoxide dismutase-mutant motor neurons.
Chung JY; Kim HJ; Kim M
BMC Neurosci; 2015 Feb; 16(1):1. PubMed ID: 25655275
[TBL] [Abstract][Full Text] [Related]
12. Edaravone in ALS.
Takahashi R
Exp Neurol; 2009 Jun; 217(2):235-6. PubMed ID: 19285071
[No Abstract] [Full Text] [Related]
13. Detection method of the adjacent motor neuronal death in an in vitro co-culture model of familial ALS-associated Cu/Zn superoxide dismutase.
Park KS; Kim HJ; Choi WJ; Kim M; Lee KW
Biotechnol Lett; 2004 Aug; 26(15):1201-5. PubMed ID: 15289674
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
[TBL] [Abstract][Full Text] [Related]
15. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?
Bacman SR; Bradley WG; Moraes CT
Mol Neurobiol; 2006 Apr; 33(2):113-31. PubMed ID: 16603792
[TBL] [Abstract][Full Text] [Related]
17. Development of novel small molecules for the treatment of ALS.
Mathew B; Ruiz P; Pathak V; Suto MJ
Bioorg Med Chem Lett; 2020 Feb; 30(4):126950. PubMed ID: 31928838
[TBL] [Abstract][Full Text] [Related]
18. Urate mitigates oxidative stress and motor neuron toxicity of astrocytes derived from ALS-linked SOD1
Bakshi R; Xu Y; Mueller KA; Chen X; Granucci E; Paganoni S; Sadri-Vakili G; Schwarzschild MA
Mol Cell Neurosci; 2018 Oct; 92():12-16. PubMed ID: 29928993
[TBL] [Abstract][Full Text] [Related]
19. Myelin degeneration induced by mutant superoxide dismutase 1 accumulation promotes amyotrophic lateral sclerosis.
Kim S; Chung AY; Na JE; Lee SJ; Jeong SH; Kim E; Sun W; Rhyu IJ; Park HC
Glia; 2019 Oct; 67(10):1910-1921. PubMed ID: 31290185
[TBL] [Abstract][Full Text] [Related]
20. Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis.
Fontanilla CV; Wei X; Zhao L; Johnstone B; Pascuzzi RM; Farlow MR; Du Y
Neuroscience; 2012 Mar; 205():185-93. PubMed ID: 22206942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
